Entering text into the input field will update the search result below

Cel-Sci (CVM +3.5%) has rallied after issuing a shareholder letter in which the company...

Nov. 30, 2012 3:10 PM ETCEL-SCI Corporation (CVM) StockCVMBy: Eric Jhonsa, SA News Editor3 Comments

Cel-Sci (CVM +3.5%) has rallied after issuing a shareholder letter in which the company expressed confidence about the outlook for Phase III trials of its Multikine immunotherapy treatment for head and neck cancer. The company also said it plans to increase the number of patient recruitment centers for the trials to at least 50, comapred with a current 36.

Recommended For You

About CVM Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CVM--
CEL-SCI Corporation